Role of Non-Coding RNAs in Post-Transcriptional Regulation of Lung Diseases

Overview

Journal Front Genet

Date 2021 Nov 25

PMID 34819948

Citations 15

Authors

Dharmendra Kumar Soni

Roopa Biswas

Affiliations

Soon will be listed here.

Abstract

Non-coding RNAs (ncRNAs), notably microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), have recently gained increasing consideration because of their versatile role as key regulators of gene expression. They adopt diverse mechanisms to regulate transcription and translation, and thereby, the function of the protein, which is associated with several major biological processes. For example, proliferation, differentiation, apoptosis, and metabolic pathways demand fine-tuning for the precise development of a specific tissue or organ. The deregulation of ncRNA expression is concomitant with multiple diseases, including lung diseases. This review highlights recent advances in the post-transcriptional regulation of miRNAs and lncRNAs in lung diseases such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and idiopathic pulmonary fibrosis. Further, we also discuss the emerging role of ncRNAs as biomarkers as well as therapeutic targets for lung diseases. However, more investigations are required to explore miRNAs and lncRNAs interaction, and their function in the regulation of mRNA expression. Understanding these mechanisms might lead to early diagnosis and the development of novel therapeutics for lung diseases.

Citing Articles

Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision.

Hamdy N, Zaki M, Abdelmaksoud N, Elshaer S, Abd-Elmawla M, Rizk N Funct Integr Genomics. 2025; 25(1):34.

PMID: 39912974 PMC: 11802690. DOI: 10.1007/s10142-025-01540-1.

Integrated analysis of long non‑coding RNA megacluster, microRNA‑132 and microRNA‑133a and their implications for cardiovascular risk and kidney failure progression in diabetic patients.

AbdElgayed G, Hosni A, Abdel-Moneim A, Malik A, Zaky M, Hasona N Exp Ther Med. 2025; 29(2):35.

PMID: 39776891 PMC: 11705225. DOI: 10.3892/etm.2024.12785.

The LINC00957/miR-17-5p axis regulates the cell cycle and migration in glioblastoma via the cuproptosis-related gene nephronectin.

Duan R, Zhao X, Hong Z, Yu L Transl Cancer Res. 2024; 13(9):4923-4937.

PMID: 39430842 PMC: 11483365. DOI: 10.21037/tcr-24-450.

Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression.

Sweef O, Mahfouz R, Tascioglu T, Albowaidey A, Abdelmonem M, Asfar M Int J Mol Sci. 2024; 25(16).

PMID: 39201688 PMC: 11354875. DOI: 10.3390/ijms25169001.

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.

Li C, Liu S Int J Mol Sci. 2024; 25(13).

PMID: 39000454 PMC: 11242201. DOI: 10.3390/ijms25137347.

References

Qu X, Dang X, Wang W, Li Y, Xu D, Shang D . Long Noncoding RNAs and mRNA Regulation in Peripheral Blood Mononuclear Cells of Patients with Chronic Obstructive Pulmonary Disease. Mediators Inflamm. 2018; 2018:7501851. PMC: 5872599. DOI: 10.1155/2018/7501851. View

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

Hangauer M, Vaughn I, McManus M . Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013; 9(6):e1003569. PMC: 3688513. DOI: 10.1371/journal.pgen.1003569. View

Zemans R, Briones N, Campbell M, McClendon J, Young S, Suzuki T . Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling. Proc Natl Acad Sci U S A. 2011; 108(38):15990-5. PMC: 3179042. DOI: 10.1073/pnas.1110144108. View

Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y . The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014; 22(6):1122-1133. PMC: 4048895. DOI: 10.1038/mt.2014.42. View

. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-596. PMC: 7284317. DOI: 10.1016/S2213-2600(20)30105-3. View

Morty R, Konigshoff M, Eickelberg O . Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009; 6(7):607-13. DOI: 10.1513/pats.200908-087RM. View

Kugel J, Goodrich J . Non-coding RNAs: key regulators of mammalian transcription. Trends Biochem Sci. 2012; 37(4):144-51. PMC: 3323709. DOI: 10.1016/j.tibs.2011.12.003. View

Ramachandran S, Karp P, Osterhaus S, Jiang P, Wohlford-Lenane C, Lennox K . Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol. 2013; 49(4):544-51. PMC: 3824042. DOI: 10.1165/rcmb.2012-0430OC. View

10.

Donnelly L, Barnes P . Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci. 2006; 27(10):546-53. DOI: 10.1016/j.tips.2006.08.001. View

11.

Choy D, Modrek B, Abbas A, Kummerfeld S, Clark H, Wu L . Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol. 2010; 186(3):1861-9. PMC: 3981556. DOI: 10.4049/jimmunol.1002568. View

12.

Zhou A, Zhao Y, Zhou Z, Duan J, Zhu Y, Cai S . Microarray Analysis of Long Non-Coding RNAs in Lung Tissues of Patients with COPD and HOXA-AS2 Promotes HPMECs Proliferation via Notch1. Int J Chron Obstruct Pulmon Dis. 2020; 15:2449-2460. PMC: 7555270. DOI: 10.2147/COPD.S259601. View

13.

Zhuang Y, Dai J, Wang Y, Zhang H, Li X, Wang C . MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition. Am J Transl Res. 2016; 8(7):3206-13. PMC: 4969458. View

14.

Jensen T, Jacquier A, Libri D . Dealing with pervasive transcription. Mol Cell. 2013; 52(4):473-84. DOI: 10.1016/j.molcel.2013.10.032. View

15.

Ye S, Zhu S, Feng L . LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma. J Clin Lab Anal. 2019; 34(3):e23092. PMC: 7083478. DOI: 10.1002/jcla.23092. View

16.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

17.

Liu Y, Yang K, Shi H, Xu J, Zhang D, Wu Y . MiR-21 modulates human airway smooth muscle cell proliferation and migration in asthma through regulation of PTEN expression. Exp Lung Res. 2015; 41(10):535-45. DOI: 10.3109/01902148.2015.1090501. View

18.

Kamikawaji K, Seki N, Watanabe M, Mataki H, Kumamoto T, Takagi K . Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. J Hum Genet. 2016; 61(12):985-993. DOI: 10.1038/jhg.2016.99. View

19.

Zeng X, Huang C, Senavirathna L, Wang P, Liu L . miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway. BMC Cell Biol. 2017; 18(1):9. PMC: 5240426. DOI: 10.1186/s12860-016-0123-7. View

20.

Luly F, Leveque M, Licursi V, Cimino G, Martin-Chouly C, Theret N . MiR-146a is over-expressed and controls IL-6 production in cystic fibrosis macrophages. Sci Rep. 2019; 9(1):16259. PMC: 6838115. DOI: 10.1038/s41598-019-52770-w. View